Health & Biotech
An Australian life science company that is the exclusive wholesale distributor for the EAORON branded skin care range to pharmacies, supermarkets and specialist retailers in Australia and New Zealand and owns, produces, designs and distributes its own range of consumer health products under the EZZ brand.
The Company has two distinct and synergistic business models: a wholesale distribution model for the EAORON branded products in the skin care segment; and an integrated model including development, production and distribution for the EZZ branded products in the consumer health segment. Synergy is created by selling the EZZ branded products to established distribution channels previously developed from selling the EAORON branded products
EZZ Life Science formulate, produce, market and distribute health supplements under the brand of EZZ, with a focus on products with significant demand from the market by consumers.
KEY PEOPLE
RELATED STOCKHEAD STORIES
News
Closing Bell: Sezzle’s got some zip, Zip’s got some sizzle and Openpay’s TTV jumps +50%
Health & Biotech
Successful navigation of a ‘difficult period’: Equity firm ups its 12-month target price for EZZ
Health & Biotech
EZZ Life Science Holdings takes big leaps for future global growth
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
EZZ’s remained ‘disciplined’ to deliver successful end to FY22
Health & Biotech
‘Revenues and profitability will steadily increase’: Equity firm says undervalued EZZ set up for future growth
News
ASX Quarterlies: Biotechs deliver strong performances for shareholders
Health & Biotech
EZZ’s cashes in on China’s multi-billion dollar e-commerce shopping festival with one product proving a winner
Health & Biotech
EZZ taps into strong consumer demand for ethically, locally made personal care products
Health & Biotech
EZZ works to catch e-commerce Southeast Asia growth wave
Health & Biotech
ASX Health Stocks: Artrya goes to America while EZZ goes live on TikTok China
Health & Biotech
EZZ to launch store on Chinese version of TikTok
Health & Biotech
EZZ posts ~$4 million cash inflows in Q3 as Covid-19 recovery continues
Health & Biotech
An ageing population is intensifying global health demand and EZZ’s life science brands are already top shelf solutions
Stockhead TV
Life Sciences: Accelerating innovation, personalised healthcare and the pandemic impact
Health & Biotech
Gastrointerest: How EZZ is working to get us all a healthy digestive system
Health & Biotech